MetLife Investment Advisors »

Sutro Biopharma shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Sutro Biopharma (STRO) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Sutro Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Sutro Biopharma held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sutro Biopharma by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $312k 9.4k 33.20

More positions owned by MetLife Investment Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Inc Class A Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Inc Class C Cap Stk Cl C (GOOG)
Micron Technology (MU)
Meta Platforms Inc Class A Cl A (META)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Advanced Micro Devices (AMD)
Berkshire Hathaway Inc Class B Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Vanguard Short-term Bond Index Fun Short Trm Bond (BSV)

View all positions for MetLife Investment Advisors

Top funds holding Sutro Biopharma

Perceptive Advisors
BVF
Affinity Asset Advisors
BlackRock
Samsara BioCapital
Kynam Capital Management
OrbiMed Advisors
Balyasny Asset Management
Vanguard Capital Management
Eventide Asset Management
Velan Capital Investment Management
Woodline Partners
ADAR1 Capital Management
Geode Capital Management
Acadian Asset Management

View all funds holding Sutro Biopharma